A 56-year-old dairy farmer received a fully HLA matched unrelated donor marrow transplant for high risk CML in chronic phase. His early post-transplant course was complicated by a series of massive intracerebral bleeds and by sepsis related to a malignant otitis externa. The microbial pathogen isolated from ear swabs was found to be Absidia corymbifera, but CT scan at the time showed no intracerebral extension. Despite neutrophil engraftment and aggressive antifungal management he succumbed. Autopsy revealed invasion of Absidia into the brain from the ear. We speculate that colonisation by Absidia resulted from occupational exposure. Bone Marrow Transplantation (2000) 26, 701-703. Keywords: zygomycosis; Absidia corymbifera; bone marrow transplantation; leukaemia Zygomycosis is an uncommon, although frequently lethal, opportunistic fungal infection caused by members of the order Mucorales most commonly Rhizopus, Absidia and Rhizomucor.
Zygomycosis is an uncommon, although frequently lethal, opportunistic fungal infection caused by members of the order Mucorales most commonly Rhizopus, Absidia and Rhizomucor. 1 These fungi are ubiquitous saprophytes found in soil, manure, plants and decayed food, and can be pathogenic in immunocompromised patients. 1 Zygomycosis is most commonly seen in patients with diabetic ketoacidosis but the incidence in those with haematological malignancies is increasing, probably as a result of newer, more aggressive chemotherapy and bone marrow transplantation regimens. 1, 2 Rhinocerebral involvement is the commonest presentation overall although pulmonary infection is more common in haematology patients. 1, 3 We describe an unusual case of zygomycosis in a dairy farmer with CML who had undergone an HLA matched unrelated donor bone marrow transplant (BMT). 
Case report
A 56-year-old dairy farmer had high risk CML, having trisomy 8 in addition to the Philadelphia chromosome. His disease had failed to respond to alpha-interferon and he therefore underwent high-dose chemotherapy, followed by a T cell-depleted, fully matched unrelated donor BMT. He was an extremely fit and well man who gave no significant past medical history. He tolerated the conditioning regimen consisting of Campath-lH, fludarabine, cyclophosphamide and single fraction TBI very well with no significant complications.
On day +4 post transplant, he complained of pain in his right ear, which had developed over the previous 12 h. Direct questioning revealed intermittent earache over several years, which he had previously not disclosed. Direct view of his right eardrum revealed no obvious erythema of the tympanic membrane which was intact. Although afebrile, swabs were taken from the ear and throat and he was commenced on piperacillin/tazobactam 4.5 g three times a day. On day +5 the pain extended to the right jaw and he developed a lower motor neurone right VIIth cranial nerve palsy. The tympanic membrane now looked swollen and erythematous with purulent material in the external auditory canal, which was thought to represent malignant otitis externa by the ENT surgeons, who recommended additional topical gentamicin drops. Urgent CT scan showed some opacification of the right mastoid with soft tissue swelling in the external canal but no osteomyelitis.
On day +6, he developed a large intracerebral bleed causing a dense left hemiparesis. Neurosurgical review suggested medical management with mannitol and dexamethasone. Later that night, he became pyrexial. Investigation revealed no additional source of infection. AmBisome was commenced empirically on day +9 at a dose of 1 mg/kg along with GM-CSF and buffy coat infusions.
On day +11, microbiology results from his initial ear swab revealed Absidia corymbifera, a Zygomycete. This organism is known to be less susceptible to amphotericin B and therefore the dose of AmBisome was increased to 5 mg/kg. Neutrophil engraftment occurred on day +11. Despite daily platelet support he had a second intracerebral bleed into the right tempero-parietal lobe (Figure 1 ) on day +12. Again, this was managed medically, with some improvement. Cerebral angiography was planned but his condition deteriorated rapidly and he died on day +15 before this was performed.
Post-mortem examination revealed that the right temporal lobe was replaced by a large haemorrhagic cavity ( Figure 2 ). There was extensive fungal invasion into the mastoid bone and into cerebral vessels and parenchyma ( Figure 3) . Absidia corymbifera was cultured from the brain tissue.
Discussion
With newer, more immunosuppressive chemotherapy and transplantation regimens fungal infections are an increasing cause of morbidity and mortality in haematology patients. Aspergillus and Candida species are the commonest cause, but rarer pathogens such as moulds of the order Mucorales are increasing. 2 Zygomycosis is an aggressive disease and mortality rates remain unacceptably high in haematology patients. A review of 30 reported cases in bone marrow transplant recipients found a mortality rate of 80%. 4 Rhinocerebral zygomycosis is the commonest clinical presentation and this usually begins in the nasal or paranasal sinuses. Fungi invade blood vessels causing a purulent arteritis and thrombosis with subsequent infarction and necrosis of tissue. Infection is aggressive and often progresses to the brain where cerebritis, infarction and abscess formation can develop.
To our knowledge, we have reported the first case of zygomycosis initially involving the ear and invading cerebral tissue. Otomycosis is most frequently caused by Aspergillus species. There has been one reported case of a patient with AML who developed an invasive middle-ear zygomycosis during neutropenia following chemotherapy. However, this patient did not develop any intracerebral complications and the infection resolved following combined treatment with surgery and liposomal amphotericin B.
5 A fatal case of zygomycosis has previously been reported in a patient with CML following allogeneic BMT. However, this patient had the classical clinical picture of rhinocerebral involvement. 4 It is of interest to note that the patient was a dairy farmer and we speculate that he became colonised with A. corymbifera following occupational exposure to the fungus. Associations between Absidia infections and farms have been previously described. A study in Finland found high airborne fungal spore concentrations, including A. corymbifera, also found in feeding and bedding materials in dairy farm barns 6 and there have been two case reports of fungal infections with A. corymbifera associated with farming. The first was of a boy who developed infection secondary to injuries sustained from becoming entrapped in a silage wagon, 7 and the second of a dairy farmer who developed keratitis after scratching his eye on a nail while working in his barn. 8 Colonisation with fungi is known to be a risk factor for invasive fungal infection (IFI) 9 and as a result, patients in our department have weekly oral and stool surveillance specimens cultured on Sabourauds agar. The patient received antifungal prophylaxis with a combination of oral itraconazole solution and amphotericin B suspension. However, Absidia is usually resistant to azoles and amphotericin B suspension acts only in the gastrointestinal tract, having no systemic activity.
Management of zygomycosis is difficult. A high index of suspicion and prompt initiation of empirical antifungal therapy is critical as once infection takes hold treatment is often ineffective. Clinical diagnosis was difficult in the patient as his signs and symptoms were unusual and developed very early after his transplant. This is surprising, in view of the fact that one of the most important risk factors for IFI is profound and prolonged neutropenia. 10 The patient had only been neutropenic for 4 days when he developed symptoms.
Zygomycosis was diagnosed following the culture of A. corymbifera from an ear swab. Definitive diagnosis requires biopsy evidence of tissue invasion by fungal hyphae, which is often only made at post mortem. 3 The classical histological appearance of mucormycosis is of large, broad, non-septate hyphae with right angle branching and distinct vascular invasion. Cultures may provide false positive results as fungi can colonise healthy individuals, but the patient clearly had active infection requiring treatment.
Aggressive and early treatment of mucormycosis is paramount, ideally with a combination of surgical removal of devitalised tissue and intravenous administration of amphotericin B.
2,3 A review of patients with pulmonary mucormycosis found that mortality was significantly lower in patients treated surgically rather than medically (11% vs 68%, P = 0.0004). 11 Unfortunately, the patient was not considered to be a suitable candidate for surgery and was treated with optimal medical therapy in the form of highdose liposomal amphotericin B. Antifungal agents penetrate infarcted tissue poorly and this is the probable reason why medical treatment alone is often ineffective. Other experimental strategies can be used such as granulocyte transfusions and cytokines such as GM-CSF. Unfortunately, despite the best treatments we currently have available most patients succumb to their infection.
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